Procter & Gamble (PG)
(Delayed Data from NYSE)
$175.47 USD
-0.43 (-0.24%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $175.62 +0.15 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$175.47 USD
-0.43 (-0.24%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $175.62 +0.15 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Zacks News
Can Coca-Cola (KO) Retain Its Positive Earnings Trend in Q4?
by Zacks Equity Research
Coca-Cola's (KO) fourth-quarter 2019 results are likely to reflect benefits from its innovation efforts, product investments, strength across regions, and robust price/mix and volume.
Here's All You Must Note Ahead of McCormick (MKC) Q4 Earnings
by Zacks Equity Research
McCormick's (MKC) fourth-quarter fiscal 2019 results are likely to reflect gains from innovation and savings from the CCI program. However, volatile currency movements are concerning.
Fourth Quarter Earnings Reports in Week Ahead
by Zacks Equity Research
Fourth Quarter Earnings Reports in Week Ahead
On MLK Day, a Busy Week Expected
by Mark Vickery
Q4 earnings season, the World Economic Forum in Davos and President Trump's impeachment trial all get underway beginning tomorrow.
The Zacks Analyst Blog Highlights: Procter & Gamble, Hill-Rom, Valero Energy and LPL Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Hill-Rom, Valero Energy and LPL Financial
Netflix, Johnson & Johnson, Procter & Gamble and Intel are part of Zacks Earnings Preview
by Zacks Equity Research
Netflix, Johnson & Johnson, Procter & Gamble and Intel are part of Zacks Earnings Preview
Hormel Foods' (HRL) Refrigerated Foods Unit Solid, Costs High
by Zacks Equity Research
Hormel Foods' (HRL) Refrigerated Foods category is steadily growing on strong brand portfolio. However, high input costs along with weakness in the Grocery and International units are concerns.
Retail Sales Scorecard 2019: ETF & Stock Winners
by Sanghamitra Saha
These industries outperformed in retail sales scorecard 2019, putting the spotlight on these ETFs and stocks.
The Zacks Analyst Blog Highlights: AAPL, JNJ, PG and AXP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AAPL, JNJ, PG and AXP
The Zacks Analyst Blog Highlights: JPM, JNJ, CVX and PG
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPM, JNJ, CVX and PG
Things to Note Ahead of Kimberly-Clark's (KMB) Q4 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter 2019 results are likely to reflect gains from Global Restructuring Program and FORCE Program. However, softness in the K-C Professional segment is a worry.
4 Growth Stocks Poised to Beat Earnings Estimates This Month
by Nalak Das
Although corporate earnings growth were negative year over year in the first three quarters, results were far better than initially anticipated.
Q4 Earnings Season Showing Revenue Momentum
by Sheraz Mian
We are starting to see clear signs of momentum on the revenue side in the Q4 results that we have seen already. This could very well be a head fake and a reflection of our desire to look for 'green shoots' in the earnings landscape...
Procter & Gamble (PG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Blue-Chip Stocks to Win Big on Phase-One Trade Deal
by Nilanjan Banerjee
Wall Street rallied following the first phase of the U.S.-China trade pact, with Dow Jones Industrial Average and S&P 500 closing at record highs.
4 Must-Buy Dow Stocks Ahead of Earnings Reports This Month
by Nalak Das
The last three months of the year were quite promising for the Dow as the U.S.-China trade war finally seemed to ease.
Snap Up 5 Mega-Cap Stocks with Impressive Growth Prospects
by Nilanjan Choudhury
Mega-caps, usually the largest and most established companies in the stock market, tend to be stable, and many of them pay dividends based on their earnings.
5 ESG Stocks to Buy as Climate Risk Takes Center Stage
by Zacks Equity Research
Recent climatic catastrophes have led investors toward climate change-related investments. Here are five stocks that fit into the climate-risk portfolio.
Lamb Weston Looks Promising on LTO Focus & Solid Price/Mix
by Zacks Equity Research
Lamb Weston (LW) is focused on efficient price/mix, buyouts and capacity expansion efforts. Further, the company is gaining from its LTO innovation.
These Stocks Will Gain From a Boom is Health Technology
by Zacks Equity Research
The current demographic trend calls for development in technology associated to healthcare. Here are three stocks that can make the most from the health technology boom.
Procter & Gamble (PG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $124.88, moving +0.73% from the previous trading session.
What's in Store for Procter & Gamble (PG) in Q2 Earnings?
by Zacks Equity Research
Procter & Gamble's (PG) second-quarter fiscal 2020 results are likely to reflect gains from organic sales and growth initiatives. Adverse currency might have been a drag.
Colgate's (CL) Growth Initiatives On Track, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) witnesses soft margins on increased raw material costs, higher SG&A expenses and currency woes. However, its innovation plans, savings program and expansion strategies might help.
McCormick (MKC) Looks Solid on Innovation & Saving Efforts
by Zacks Equity Research
McCormick (MKC) is on track with the CCI program to boost savings. Also, the company's focus on new product launches is augmenting its market share.
Helen of Troy (HELE) Q3 Earnings & Sales Rise Y/Y, Stock up
by Zacks Equity Research
Helen of Troy's (HELE) Q3 earnings and sales increase year over year on strength in the Housewares and Beauty segment. However, the Health & Home segment looks troubled.